Pharmacokinetics, Safety and Tolerability of Pilabactam (formerly ANT3310) Combined with Meropenem in Participants with Impaired Renal Function​

Apr 27, 2026

J. Dao, C. Zwingelstein, A.C. Benichou, L. Fabre, B. Chukwumezie​

Penetration of Pilabactam (Formerly ANT3310) and Meropenem into Pulmonary Epithelial Lining Fluid in Healthy Adult Participants

Apr 27, 2026

J. Dao, C. Zwingelstein, A.C. Benichou, L. Fabre, K. Rodvold, M. Gotfried, J. Burr Ross​

Potent Activity of the Novel Combination Meropenem-pilabactam (Formerly ANT3310) Against Global Acinetobacter baumannii Clinical Isolates from 2019 to 2023

Apr 27, 2026

C. Da Silva, A. Alary, M.I. Ancora, M. Estel Wattel, S. Hawser, M. Hackel, A. Ledoux, M. Lemonnier, M. Zalacain, A. Llano

Potent Activity of the Novel Combination Meropenem-pilabactam (Formerly ANT3310) Against Global OXA- and KPC-Carbapenem-Resistant Enterobacterales (CRE) Clinical Isolates from 2019 to 2023

Apr 27, 2026

C. Da Silva, A. Alary, M.I. Ancora, S. Hawser, M. Hackel, A. Ledoux, M. Lemonnier, M. Zalacain, A. Llanos